Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
Ting-Ting HanYi-Ning ZhangYu-Qian SunJun KongFeng-Rong WangZhi-Dong WangYi-Fei ChengChen-Hua YanYu WangLan-Ping XuXiao-Hui ZhangKai-Yan LiuXiao-Jun HuangXiao-Jun HuangPublished in: Transplant infectious disease : an official journal of the Transplantation Society (2021)
The reactivation of HHV-6 after unmanipulated haploidentical transplantation predicts the occurrence of grade 2-4 a-GVHD, but it may not influence the overall survival (OS), disease-free survival (DFS) and non-relapse mortality (NRM).
Keyphrases
- free survival
- stem cell transplantation
- risk assessment
- bone marrow
- peripheral blood
- endothelial cells
- liver failure
- acute myeloid leukemia
- cardiovascular events
- cord blood
- respiratory failure
- induced pluripotent stem cells
- high dose
- allogeneic hematopoietic stem cell transplantation
- drug induced
- risk factors
- aortic dissection
- stem cells
- type diabetes
- cell therapy
- cardiovascular disease
- mesenchymal stem cells
- intensive care unit